These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4091030)

  • 21. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.
    Jones TH; Figueroa CD; Smith CM; Bhoola KD
    Agents Actions Suppl; 1992; 38 ( Pt 2)():175-82. PubMed ID: 1462825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolactinoma during pregnancy causing compression symptoms responding to bromocriptine therapy.
    Saunders NJ
    Postgrad Med J; 1985 Sep; 61(719):829-30. PubMed ID: 4059146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prolactin and pregnancy].
    Miyakawa I
    Rinsho Byori; 1989 Aug; 37(8):862-7. PubMed ID: 2585752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perifusion studies of bromocriptine-treated and untreated macroprolactinomas: effects of dopamine, bromocriptine and TRH.
    Bevan JS; Burke CW
    Clin Endocrinol (Oxf); 1989 Jun; 30(6):667-80. PubMed ID: 2512041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visual field defects and reduced visual acuity during pregnancy in two patients with prolactinoma: rapid regression of symptoms under bromocriptine. Case reports.
    Crosignani P; Ferrari C; Mattei AM
    Br J Obstet Gynaecol; 1984 Aug; 91(8):821-3. PubMed ID: 6466586
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of prolactin-secreting pituitary tumors with bromocriptine].
    Katzir D; Rosenberg T; Ramot Y; Gaver-Shavit A; Gilboa Y
    Harefuah; 1990 Feb; 118(3):141-5. PubMed ID: 2341064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bromocriptine reduces the size of cells in prolactin-secreting pituitary adenomas.
    Landolt AM; Minder H; Osterwalder V; Landolt TA
    Experientia; 1983 Jun; 39(6):625-6. PubMed ID: 6852202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A giant prolactinoma and the effect of chronic bromocriptine therapy on basal and TRH-stimulated serum prolactin levels.
    Barrera CM; Ruiz AE; Banks WA
    Horm Res; 1991; 35(3-4):167-9. PubMed ID: 1806471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid rhinorrhea during treatment with bromocriptine for prolactinoma.
    Kok JG; Bartelink AK; Schulte BP; Smals A; Pieters G; Meyer E; Merx H
    Neurology; 1985 Aug; 35(8):1193-5. PubMed ID: 4022353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aldosterone response to metoclopramide in patients with prolactinoma: effect of short-term bromocriptine treatment.
    Zacharieva S; Stoeva I; Andreeva M; Kalinov K; Matrozov P; Andonova K
    Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):593-7. PubMed ID: 9010834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the new dopaminergic agonist CV 205-502 on plasma prolactin levels and tumour size in bromocriptine-resistant prolactinomas.
    Duranteau L; Chanson P; Lavoinne A; Horlait S; Lubetzki J; Kuhn JM
    Clin Endocrinol (Oxf); 1991 Jan; 34(1):25-9. PubMed ID: 1672268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance to bromocriptine in prolactinomas.
    Pellegrini I; Rasolonjanahary R; Gunz G; Bertrand P; Delivet S; Jedynak CP; Kordon C; Peillon F; Jaquet P; Enjalbert A
    J Clin Endocrinol Metab; 1989 Sep; 69(3):500-9. PubMed ID: 2760167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Bromocriptine for macroprolactinomas. Discussion of 3 cases treated successfully].
    Sapunar J; López JM; Huete I; Tagle R
    Rev Med Chil; 1992 Feb; 120(2):168-73. PubMed ID: 1340555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of quinagolide in resistance to dopamine agonists: results of a multicenter study. Club de l'Hypophyse.
    Rohmer V; Freneau E; Morange I; Simonetta C
    Ann Endocrinol (Paris); 2000 Nov; 61(5):411-7. PubMed ID: 11084391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Long-term bromocriptine treatment of giant prolactinoma: report of a case].
    Mashio Y; Beniko M; Ikota A; Mizumoto H; Sato S; Yamaguchi O; Suzuki S; Tashiro T; Ikota T
    Nihon Naika Gakkai Zasshi; 1989 Dec; 78(12):1785-6. PubMed ID: 2625603
    [No Abstract]   [Full Text] [Related]  

  • 36. Enlargement of a prolactin-secreting pituitary microadenoma during bromocriptine treatment. Case report.
    Crosignani PG; Mattei A; Ferrari C; Giovanelli MA
    Br J Obstet Gynaecol; 1982 Feb; 89(2):169-70. PubMed ID: 7066250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prolactinoma in a child showing high MIB-1 labeling index: a case report].
    Akamine S; Miyamoto T; Sugiura Y; Takehara S; Hiramatsu H; Nishizawa S; Yokota N
    No Shinkei Geka; 2000 Jun; 28(6):547-53. PubMed ID: 10875113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Size reduction of a large prolactinoma by bromocriptine treatment. Report of a case.
    Matsumura S; Mori S; Uozumi T
    Neurol Med Chir (Tokyo); 1981 Jan; 21(1):127-30. PubMed ID: 6168944
    [No Abstract]   [Full Text] [Related]  

  • 39. Interactions between thioridazine and bromocriptine in a patient with a prolactin-secreting pituitary adenoma.
    Robbins RJ; Kern PA; Thompson TL
    Am J Med; 1984 May; 76(5):921-3. PubMed ID: 6720732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastasis of an occult gastric carcinoma suggesting growth of a prolactinoma during bromocriptine therapy: a case report with a review of the literature.
    van Seters AP; Bots GT; van Dulken H; Luyendijk W; Vielvoye GJ
    Neurosurgery; 1985 Jun; 16(6):813-7. PubMed ID: 2989726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.